4.910USD+0.20%Mkt Cap: 228.30M USDP/E: —Last update: 2026-06-01
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candi…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap228.30M USD
Enterprise Value215.65M USD
Revenue (TTM)—
Gross Profit-9.65M USD
Net Income (TTM)-293.42M USD
Revenue/Share—
Last Price4.910 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6033802058
Valuation
P/E (Trailing)—
P/E (Forward)-10.23
PEG—
EV/EBITDA-7.74
EV/Revenue—
P/S—
P/B-0.85
EPS (TTM)-37.03
EPS (Forward)-0.48
52W Range
1.51431% of range12.46
52W High12.46 USD
52W Low1.514 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE208.47%
ROA-299.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.51M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-2.43%
Net Debt-18.06M USD
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity—
Current Ratio17.65
Quick Ratio17.42
Book Value/Sh-5.7940 USD
Cash/Share1.676 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateJun 21, 2022
Analyst Consensus
Rating2.7 (Hold)
Target (Mean)9.500 USD
Target Range7.000 USD – 14.00 USD
# Analysts3
Ownership
Shares Out.46.59M
Float30.87M
Insiders3.34%
Institutions89.53%
Short Interest
Short Ratio8.1d
Short % Float2.67%
Short % Out.2.55%
Shares Short1.19M
Short (prev mo.)1.16M
Technical
SMA 506.006 (-18.2%)
SMA 2004.492 (+9.3%)
Beta-0.10
S&P 52W Chg27.94%
Avg Vol (30d)137.51K
Avg Vol (10d)166.19K
Technical Indicators
RSI (14)38.7
MACD-0.3095
MACD Signal-0.2981
MACD Hist.-0.0114
BB Upper6.564 USD
BB Middle5.481 USD
BB Lower4.399 USD
BB Width39.50%
ATR (14)0.4418 USD
Vol Ratio (20d)0.25x